Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study
Hemodialysis International · 2020-01 · 24 (1) · 43-51
DOI: 10.1111/hdi.12798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hemodialysis International, 2019-12. Verfasst von Ali I Gardezi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: American Society of Diagnostic and Interventional Nephrology.
Abstract (Originalsprache)
Introduction
Vascular access dysfunction is a major cause of morbidity in patients with end‐stage renal disease (ESRD) on chronic hemodialysis. The effects of abnormalities in mineral metabolism on vascular access are unclear. In this study, we evaluated the association of mineral metabolites, including 25‐hydroxy vitamin D (25(OH)D) and fibroblast growth factor‐23 (FGF‐23), with vascular access complications.
Methods
We included participants from the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study who were using an arteriovenous fistula (AVF; n = 103) or arteriovenous graft (AVG; n = 116). Serum levels of 25(OH)D, FGF‐23, parathyroid hormone (PTH), calcium, phosphorus, C‐reactive protein (CRP) and interleukin‐6 (IL‐6) were assessed from stored samples. Participants were followed for up to 1 year or until a vascular access intervention or replacement.
Findings
A total of 24 participants using an AVF and 43 participants using an AVG experienced access intervention. Those with 25(OH)D level in the lowest tertile (3750 RU/mL) was associated with greater risk of AVF intervention (aHR = 2.56; 95% CI: 1.06, 6.18). Higher PTH was associated with higher risk of AVF intervention (aHR = 1.64 per SD of log(PTH); 95% CI: 1.02, 2.62). These associations were not observed in participants using an AVG. None of the other analytes were significantly associated with AVF or AVG intervention.
Discussion
Low levels of 25(OH)D and high levels of FGF‐23 and PTH are associated with increased risk of AVF intervention. Abnormalities in mineral metabolism are risk factors for vascular access dysfunction and potential therapeutic targets to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Medicine, University of California, San Francisco, California, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Pediatrics and Medicine, Hospital for Sick Children, University Health Network and University of Toronto, Toronto, Canada.
ORCID-Profile: Ali I Gardezi
Förderung
- American Society of Diagnostic and Interventional Nephrology
Zitieren
APA
Gardezi, A. I., Karim, M. S., Rosenberg, J. E., Scialla, J. J., Banerjee, T., Powe, N. R., Shafi, T., Parekh, R. S., Yevzlin, A. S., & Astor, B. C. (2020). Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodialysis International, 24(1), 43-51. https://doi.org/10.1111/hdi.12798
Vancouver
Gardezi AI, Karim MS, Rosenberg JE, Scialla JJ, Banerjee T, Powe NR, et al. Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodialysis International. 2020;24(1):43-51. doi:10.1111/hdi.12798
BibTeX
@article{Gardezi2020,
author = {Gardezi, Ali I and Karim, Muhammad S and Rosenberg, Joel E and Scialla, Julia J and Banerjee, Tanushree and Powe, Neil R and Shafi, Tariq and Parekh, Rulan S and Yevzlin, Alexander S and Astor, Brad C},
title = {Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study},
journal = {Hemodialysis International},
year = {2020},
volume = {24},
number = {1},
pages = {43--51},
doi = {10.1111/hdi.12798}
}
EUVIMED